# MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) is experiencing significant social media buzz driven by speculation of a potential buyout or short squeeze, alongside anticipation for FDA approval. This optimism is currently overshadowing negative clinical trial results and insider selling.

### About MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics is a biotechnology company developing novel immunotherapies.  
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) social dominance is up 58.14% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) engagements is up 141.64% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) mentions is up 14.1% from the previous week.
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up 171.43% from the previous week.

### Price: $15.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/close.tsv)  
Current price action is driven by speculation of a potential buyout or short squeeze and positive anticipation of FDA approval, which are currently outweighing negative clinical trial results and insider selling, despite a recent downgrade from Goldman Sachs.  

24-Hour: 0.45%
7-Day: 1.68%
30-Day: -5.91%

1-Year High: $62 on 2025-09-26  
1-Year Low: $6.20 on 2025-09-29  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/alt_rank.tsv)  
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #973 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +122  
[--] Month: [---] +471  
[--] Months: [---] +627  
[--] Year: [---] [----]  
1-Year High: [-----] on 2026-02-04  
1-Year Low: [--] on 2025-09-29  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +1  
[--] Month: [--] +6  
[--] Months: [--] +4  
[--] Year: [--] +6  
1-Year High: [--] on 2026-01-08  
1-Year Low: [--] on 2025-12-30  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +142%  
[--] Month: [-------] -67%  
[--] Months: [---------] +97%  
[--] Year: [---------] +192%  
1-Year High: [-------] on 2025-09-29  
1-Year Low: [---] on 2025-04-18  

Engagements by network (24h):
X: [-----]
Reddit: [--]
YouTube: [--]
TikTok: [--]
News: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +14%  
[--] Month: [---] -25%  
[--] Months: [-----] +73%  
[--] Year: [-----] +170%  
1-Year High: [---] on 2026-01-09  
1-Year Low: [--] on 2025-04-18  

Mentions by network (24h):
X: [--]
Reddit: [--]
YouTube: [--]
TikTok: [--]
News: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last [--] hours which is up 7% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +7.80%  
[--] Month: [---] -20%  
[--] Months: [-----] +6.60%  
[--] Year: [-----] +197%  
1-Year High: [---] on 2026-01-09  
1-Year Low: [--] on 2025-04-19  

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | [--]    | [------]    | [--]     | [-----]       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [-----]       |
| [@amazing_stocks](/creator/twitter/amazing_stocks)   | [--]    | [---]       | [--]     | [---]         |
| [@Biotekster](/creator/twitter/Biotekster)           | [--]    | [---]       | [--]     | [---]         |
| [@ABBONews](/creator/twitter/ABBONews)               | [--]    | [-----]     | [--]     | [--]          |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [--]          |
| [@BullBearInvests](/creator/twitter/BullBearInvests) | [--]    | [--]        | [--]     | [--]          |
| [@Kleem48044](/creator/twitter/Kleem48044)           | [--]    | [--]         | [--]     | [--]          |
| [@Ella44734](/creator/twitter/Ella44734)             | [--]    | [--]         | [--]     | [--]          |
| [@RitterJoleen](/creator/twitter/RitterJoleen)       | [--]   | [---]       | [--]     | [--]          |

[View More](/list/creators/$mltx/100)
  
  
### Sentiment: 70%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/sentiment.tsv)  
Current Value: 70%  
Daily Average: 74%  
[--] Week: 100% no change  
[--] Month: 59% -22%  
[--] Months: 59% -36%  
[--] Year: 59% -1%  
1-Year High: 100% on 2025-02-24  
1-Year Low: 20% on 2025-04-29  

Most Supportive Themes:
- Positive FDA Approval Anticipation: (30%) Optimism surrounding an upcoming FDA decision is driving positive sentiment and investor interest.
- Potential Buyout Speculation: (30%) Market participants are discussing the possibility of a company acquisition, which could lead to a significant price increase.
- Short Squeeze Opportunity: (25%) Social media buzz suggests a potential short squeeze, attracting traders looking for rapid gains.
  
Most Critical Themes:
- Negative Clinical Trial Results: (15%) Recent trial data has been unfavorable, raising concerns about the company's drug development pipeline.
- Insider Selling: (10%) A significant insider sale has been noted, which can be interpreted as a negative signal by the market.
  
  
  
### Social Dominance: 0.00449%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/social_dominance.tsv)  
Current Value: 0.00449%  
Daily Average: 0.012%  
[--] Week: 0.0068% +0.0025%  
[--] Month: 0.0084% -0.015%  
[--] Months: 0.0084% -0.0015%  
[--] Year: 0.0084% +0.0018%  
1-Year High: 0.10% on 2026-01-09  
1-Year Low: 0.0025% on 2025-04-18  
  
  
### Market Dominance: 0.00127%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/market_dominance.tsv)  
Current Value: 0.00127%  
Daily Average: 0%  
1-Year High: 0.089% on 2025-03-27  
1-Year Low: 0.00049% on 2025-09-29  
  
  
### Market Cap: $1,117,263,514
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mltx/time-series/market_cap.tsv)  
Current Value: $1,117,263,514  
Daily Average: $2,142,782,699  
[--] Week: $1,117,263,514 +1.70%  
[--] Month: $1,117,263,514 -3.60%  
[--] Months: $1,117,263,514 -67%  
[--] Year: $1,117,263,514 -59%  
1-Year High: $3,936,451,910 on 2025-09-26  
1-Year Low: $396,566,255 on 2025-09-29  

### Top MoonLake Immunotherapeutics Class A Ordinary Shares Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"This article on Sanofi CEO change quotes a Jefferies analyst who agrees with my view that there is little rhyme or reason in I&I drug development. In fact I'm wondering whether because of it the healthcare system is wasting much money here on expensive specialty drugs that in the end don't really add much. $mltx $nktr $abvx etc https://endpoints.news/sanofis-new-ceo-belen-garijo-gets-frosty-reception-as-challenges-await/ https://endpoints.news/sanofis-new-ceo-belen-garijo-gets-frosty-reception-as-challenges-await/"  
[X Link](https://x.com/RNAiAnalyst/status/2022663557683314956) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-14T13:25Z 21.2K followers, [----] engagements


"$beam $qure $mltx what to make of any positive regulatory 'alignments' when leftist saboteur Prasad can interject himself last minute $qure alignment e.g. last year occurred under new admin so this does not only impact developments started under old FDA"  
[X Link](https://x.com/RNAiAnalyst/status/2022606342842978549) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-14T09:38Z 21.2K followers, [----] engagements


"Vivo need to double check but upon quick look it seems new last Q: $ABVX $ANRO $CAMP $DNTH $DSGN $EPRX $LBRX $MLTX $MNPR $NERV $PALI $PEPG etc"  
[X Link](https://x.com/zohmbastic/status/2022394828991172926) [@zohmbastic](/creator/x/zohmbastic) 2026-02-13T19:37Z 10.1K followers, [----] engagements


"My watch list of catalysts- update 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD $PVLA Ph3 mLM My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC"  
[X Link](https://x.com/Andre_AGTC/status/2022077136581083568) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-12T22:35Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing